BGC20-1531

DRUG2 trials

Sponsors

Boston Scientific Corporation, Danish Headache Center

Conditions

Headache, MigraineMigraine

Phase 1

EP4-receptor Antagonism and Prostaglandin E2 (PGE2) in a Human Headache Model

CompletedNCT00957983

Danish Headache CenterHeadache, Migraine

Start: 2009-08-31End: 2010-02-28Updated: 2011-01-11

Phase 2

Double-blind, Placebo-controlled Study of BGC20-1531 in Migraine

WithdrawnNCT00888680

Boston Scientific CorporationMigraine

Updated: 2022-06-03